Ms. Charité Ricker, MS, CGC and Dr. Nadine Tung, MD, FASCO share updates from the new ASCO guideline on selection of germline genetic testing panels in patients with cancer. They discuss highlights on ...
Stephen Liu, MD, and Danielle Hicks illustrate how molecular testing impacts targeted therapy selection in non-small cell lung cancer. Stephen Liu, MD: So, when you think of biomarker testing and the ...
Noninvasive Colorectal Cancer Screening: Efficacy, Patient Selection, and Impact on Invasive Testing
Patients with an average risk for colorectal cancer (CRC) are candidates for noninvasive tests, such as multitarget stool DNA (mtsDNA), whereas those with a higher risk, including those with a family ...
Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Noninvasive Colorectal Cancer Screening: Efficacy, Patient Selection, and Impact on Invasive Testing
Since the early 2000s, CRC mortality has significantly decreased, largely due to advancements in screening and the removal of precancerous polyps. However, CRC continues to be the second most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results